Iambic Therapeutics, Inc.

Amendment
CIK: 0001997038·Biotechnology·DELAWARE·Filed: Jun 6, 2024
Total Offering

$49,999,998

Amount Sold

$38,383,040

Investors

11

First Sale

Apr 15, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2019
Non-Accredited Investors
No

Related Persons

NameRole
R. Jacob Vogelstein
Related Person
Tabbert Teng
Related Person
Thomas Miller
Related Person
Jishnu Bhattacharjee
Related Person
Neil Josephson
Related Person
Fred Manby
Related Person
Evan Rachlin
Related Person
William Rastetter
Related Person
Kurt von Emster
Related Person

Company

Iambic Therapeutics, Inc.

5627 OBERLIN DRIVE, SUITE 120

SAN DIEGO, CA, 92121

(626) 592-2520

SEC Filing

0001997038-24-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free